APACC 2020

Program - Abstract submissionScholarships - Registration - Venue & practical infoAPACC 2019 

What's New

  • We have been closely monitoring the situation with the COVID-19 outbreaks in the Asia-Pacific region. Attendees who are impacted by and are unable to attend APACC 2020 due to travel restrictions will be offered refunds on their registration fees. 
  • Check out the list of confirmed speakers and topics. Also join the pre-meetings: Asia Pacific HIV Clinical Forum on 3 June, and Asian Stigma & Discrimination Forum on 4 June.
  • Scholarships application opens until 3 April. More details.
  • Abstract submission opens until 30 March. Co-submission of abstracts to APACC 2020 and AIDS 2020 is allowed. More details.
  • Thai Airways is offering special fares to our attendees to travel to the event in Bangkok. More details.

Program at a glance_APACC2020


 

 


Welcome Message

Dear colleagues,

It is our pleasure to announce that the Asia Pacific AIDS & Co-Infections Conference (APACC) 2020 is scheduled to take place in Bangkok, Thailand on 4 - 6 June 2020.

Over the years, enormous progress has been made in the fight against HIV and co-infections with HIV. Both academia and industry have contributed greatly to equipping the medical community with the best medications and expertise possible to optimally treat their HIV and co-infected patients. However, the international platforms for scientific interchange are not always accessible to medical professionals worldwide due to budget and travel restrictions. Also, most major conferences do not usually address local and regional issues. In particular, the Asian medical community in this field of research currently has very few platforms that serve the needs of HIV healthcare professionals in this region.

APACC provides a much-needed scientific platform that focuses on the developments, issues, and needs in the Asia Pacific region. Researchers have the opportunity to present and discuss the latest developments and are offered opportunities for interaction, networking, and building collaborations. Top experts integrate science and clinical practice through state-of-the-art lectures, clinical case discussions, round table discussions, and debates in order to reach consensus on best practices and inform how treatment guidelines are implemented.

We look forward to welcoming you at APACC 2020!

Chairs 2020


Unique Features

  • A program with special focus on the needs in Asia and the Pacific
  • A true scientific platform for regional clinicians and clinical researchers to present their data
  • Insights into important clinical developments and updates on ongoing and new trials
  • Capacity building workshops and career development sessions for young professionals
  • A great opportunity to network with your colleagues throughout Asia

Who Should Attend?

  • Medical professionals involved in daily care of individuals infected with HIV and HIV-HCV, HIV-HBV, HIV-TB, and other HIV co-infections
  • Clinical, translational, and basic researchers
  • Clinicians, physicians, general practitioners, and nurses
  • Residents, post-graduates, and PhD students
  • Government agency personnel, NGO representatives,and  health authority personnel
  • Industry representatives
  • Social workers, advocates, and community workers
  • Other healthcare professionals involved in treating HIV and co-infected patients

 


Meeting Objectives

This meeting aims to:

  • Promote dissemination and successful translation of new knowledge regarding HIV and co-infections while facilitating a neutral environment
  • Foster new and lasting cross-disciplinary partnerships and collaborations between researchers in HIV, hepatitis, tuberculosis, policy makers, and NGOs, among others, in order to improve  knowledge sharing, with the end goal of improving health span within the rapidly growing HIV/AIDS population
  • Attract, showcase, and maintain new, early career, and underrepresented investigators to this multidisciplinary area of research and to translate novel findings into clinical practice

Learning Objectives

After participating in this activity, the participants will be able:

  • Describe the major achievements and challenges in antiviral therapy for HIV and/or hepatitis-positive patients in the Asia Pacific region 
  • Identify improved treatment options for their patients
  • Initiate (research) collaborations to further improve the level of knowledge on clinical management in the Asia Pacific region
  • Use gained knowledge to make/advocate for appropriate adjustments to policies in public, institutional, and private settings